Categories
-
Wal-Mart
- General Motors
- Dow Jones
- Goldman Sachs
- Accor
- Renault
- Reuters
- BNP Paribas
- Toyota
- AgBank
- Microsoft
- Intel
- ALCATEL-LUCENT
- AXA
- Japan Airlines
- Agricultural Bank of China
- Lucien Barri
- CITIGROUP
- toutes nos catégories
Tags
Health Canada approves Novartis' Afinitor to treat patients with mRCCNovartis Pharmaceuticals Canada Inc. (Novartis) announced today that Afinitor(R) (everolimus), a once-daily oral cancer treatment, has been approved by Health Canada for patients with metastatic renal cell carcinoma (mRCC), also known as advanced kidney cancer, after failure of initial treatment with VEGF-receptor targeted therapies Sutent(R) (sunitinib) or Nexavar(R) (sorafenib).
2010-01-20 - News-Medical-Net